Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 19-Nov-24 4:04 PM View:  | Stokes Frank Chief Financial Officer | Castle Biosciences Inc (CSTL) | 15-Nov-24 | Sale (Planned) | 6,923 | $29.93 | $207,217.00 | (18%) 37.75K to 30.82K | |
| 14-Nov-24 6:21 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 12-Nov-24 | Market Sale (Planned) | 3,155 | $34.15 | $107,743.00 | (< 1%) 403.0K to 399.84K | (18%) |
| 14-Nov-24 6:21 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 12-Nov-24 | Market Sale (Planned) | 1,972 | $34.15 | $67,343.80 | (< 1%) 404.97K to 403.0K | (18%) |
| 16-Oct-24 4:34 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 14-Oct-24 | Sale (Planned) | 3,155 | $32.27 | $101,821.00 | (< 1%) 413.25K to 410.09K | |
| 16-Oct-24 4:34 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 14-Oct-24 | Sale (Planned) | 1,972 | $32.27 | $63,642.40 | (< 1%) 415.22K to 413.25K | |
| 10-Oct-24 4:22 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 08-Oct-24 | Sale (Planned) | 986 | $30.27 | $29,845.20 | (< 1%) 417.78K to 416.8K | |
| 10-Oct-24 4:22 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 08-Oct-24 | Sale (Planned) | 1,576 | $30.27 | $47,703.90 | (< 1%) 416.8K to 415.22K | |
| 09-Oct-24 4:30 PM View: | Bradbury Daniel Director | Castle Biosciences Inc (CSTL) | 07-Oct-24 | Sale (Planned) | 7,867 | $29.44 | $231,628.00 | (15%) 52.63K to 44.76K | |
| 08-Oct-24 4:48 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 04-Oct-24 | Sale (Planned) | 986 | $28.73 | $28,331.70 | (< 1%) 420.35K to 419.36K | |
| 08-Oct-24 4:48 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 04-Oct-24 | Sale (Planned) | 1,579 | $28.73 | $45,371.00 | (< 1%) 419.36K to 417.78K | |
| 18-Sep-24 4:23 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 16-Sep-24 | Sale (Planned) | 3,155 | $30.97 | $97,716.70 | (< 1%) 423.5K to 420.35K | |
| 18-Sep-24 4:23 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 16-Sep-24 | Sale (Planned) | 1,972 | $30.97 | $61,076.80 | (< 1%) 425.48K to 423.5K | |
| 13-Sep-24 4:33 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 11-Sep-24 | Sale (Planned) | 996 | $30.32 | $30,198.70 | (< 1%) 428.09K to 427.1K | |
| 13-Sep-24 4:33 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 11-Sep-24 | Sale (Planned) | 1,620 | $30.32 | $49,118.40 | (< 1%) 427.1K to 425.48K | |
| 11-Sep-24 4:15 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 09-Sep-24 | Sale (Planned) | 996 | $29.46 | $29,339.20 | (< 1%) 430.68K to 429.68K | |
| 11-Sep-24 4:15 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 09-Sep-24 | Sale (Planned) | 1,590 | $29.46 | $46,836.60 | (< 1%) 429.68K to 428.09K | |
| 09-Sep-24 4:06 PM View: | Bradbury Daniel Director | Castle Biosciences Inc (CSTL) | 05-Sep-24 | Sale (Planned) | 7,867 | $29.02 | $228,332.00 | (13%) 60.49K to 52.63K | |
| 05-Sep-24 4:07 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 04-Sep-24 | Sale (Planned) | 500 | $30.02 | $15,012.00 | (< 1%) 431.18K to 430.68K | |
| 05-Sep-24 4:07 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 04-Sep-24 | Sale (Planned) | 298 | $30.02 | $8,947.15 | (< 1%) 431.48K to 431.18K | |
| 05-Sep-24 4:07 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 03-Sep-24 | Sale (Planned) | 417 | $30.05 | $12,530.00 | (< 1%) 432.59K to 432.17K | |
| 05-Sep-24 4:07 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 03-Sep-24 | Sale (Planned) | 699 | $30.05 | $21,003.60 | (< 1%) 432.17K to 431.48K | |
| 05-Sep-24 4:06 PM View: | Oelschlager Kristen M Chief Operating Officer | Castle Biosciences Inc (CSTL) | 03-Sep-24 | Sale (Planned) | 5,832 | $29.21 | $170,330.00 | (4%) 140.67K to 134.84K | |
| 03-Sep-24 4:08 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 30-Aug-24 | Sale (Planned) | 322 | $30.10 | $9,691.88 | (< 1%) 433.45K to 433.13K | |
| 03-Sep-24 4:08 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 30-Aug-24 | Sale (Planned) | 539 | $30.10 | $16,223.40 | (< 1%) 433.13K to 432.59K | |
| 03-Sep-24 4:08 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 29-Aug-24 | Sale (Planned) | 2,246 | $30.08 | $67,548.50 | (< 1%) 435.7K to 433.45K | |
| 03-Sep-24 4:08 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 29-Aug-24 | Sale (Planned) | 1,334 | $30.08 | $40,120.10 | (< 1%) 437.03K to 435.7K | |
| 14-Aug-24 4:53 PM View: | Bradbury Daniel Director | Castle Biosciences Inc (CSTL) | 12-Aug-24 | Sale (Planned) | 7,883 | $26.65 | $210,058.00 | (12%) 68.38K to 60.49K | |
| 13-Aug-24 6:14 PM View: | Stokes Frank Chief Financial Officer | Castle Biosciences Inc (CSTL) | 09-Aug-24 | Grant | 9,745 | -- | -- | 32% 30.82K to 40.57K | |
| 13-Aug-24 6:16 PM View: | Juvenal Tobin W Chief Commercial Officer | Castle Biosciences Inc (CSTL) | 09-Aug-24 | Grant | 10,641 | -- | -- | 21% 50.36K to 61.0K | |
| 13-Aug-24 6:15 PM View: | Oelschlager Kristen M Chief Operating Officer | Castle Biosciences Inc (CSTL) | 09-Aug-24 | Grant | 10,641 | -- | -- | 8% 132.84K to 143.48K | |
| 13-Aug-24 6:17 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 09-Aug-24 | Grant | 66,991 | -- | -- | 17% 394.86K to 461.85K | |
| 13-Aug-24 6:14 PM View: | Stokes Frank Chief Financial Officer | Castle Biosciences Inc (CSTL) | 09-Aug-24 | Payment of Exercise | 2,822 | $26.83 | $75,714.30 | (7%) 40.57K to 37.75K | |
| 13-Aug-24 6:16 PM View: | Juvenal Tobin W Chief Commercial Officer | Castle Biosciences Inc (CSTL) | 09-Aug-24 | Payment of Exercise | 2,592 | $26.83 | $69,543.40 | (4%) 61.0K to 58.41K | |
| 13-Aug-24 6:15 PM View: | Oelschlager Kristen M Chief Operating Officer | Castle Biosciences Inc (CSTL) | 09-Aug-24 | Payment of Exercise | 2,804 | $26.83 | $75,231.30 | (2%) 143.48K to 140.67K | |
| 13-Aug-24 6:17 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 09-Aug-24 | Payment of Exercise | 21,828 | $26.83 | $585,645.00 | (5%) 461.85K to 440.02K | |
| 13-Aug-24 6:13 PM View: | Stokes Frank Chief Financial Officer | Castle Biosciences Inc (CSTL) | 07-Aug-24 | Sale (Planned) | 10,000 | $25.70 | $256,997.00 | (24%) 40.82K to 30.82K | |
| 05-Aug-24 4:16 PM View: | Oelschlager Kristen M Chief Operating Officer | Castle Biosciences Inc (CSTL) | 01-Aug-24 | Sale (Planned) | 12,989 | $23.06 | $299,503.00 | (9%) 145.82K to 132.84K | |
| 31-Jul-24 4:50 PM View: | Oelschlager Kristen M Chief Operating Officer | Castle Biosciences Inc (CSTL) | 29-Jul-24 | Sale (Planned) | 2,793 | $22.06 | $61,622.00 | (2%) 148.62K to 145.82K | |
| 16-Jul-24 4:51 PM View: | Caple Kim Director | Castle Biosciences Inc (CSTL) | 14-Jul-24 | Option Exercise | 440 | -- | -- | 3% 13.34K to 13.78K | |
| 16-Jul-24 4:49 PM View: | Goldberg Ellen Director | Castle Biosciences Inc (CSTL) | 14-Jul-24 | Option Exercise | 440 | -- | -- | 2% 18.14K to 18.58K | |
| 03-Jul-24 4:15 PM View: | Oelschlager Kristen M Chief Operating Officer | Castle Biosciences Inc (CSTL) | 01-Jul-24 | Sale (Planned) | 2,793 | $21.22 | $59,278.60 | (2%) 151.41K to 148.62K | |
| 05-Jun-24 5:23 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 03-Jun-24 | Sale (Planned) | 40 | $23.98 | $959.16 | (< 1%) 394.96K to 394.92K | |
| 05-Jun-24 5:23 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 03-Jun-24 | Sale (Planned) | 2,328 | $23.39 | $54,456.60 | (< 1%) 401.19K to 398.86K | |
| 05-Jun-24 5:23 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 03-Jun-24 | Sale (Planned) | 64 | $23.98 | $1,534.66 | (< 1%) 394.92K to 394.86K | |
| 05-Jun-24 5:23 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 03-Jun-24 | Sale (Planned) | 3,904 | $23.39 | $91,322.40 | (< 1%) 398.86K to 394.96K | |
| 29-May-24 4:40 PM View: | Harrison Miles Director | Castle Biosciences Inc (CSTL) | 25-May-24 | Option Exercise | 8,636 | -- | -- | 186% 4.66K to 13.29K | |
| 29-May-24 4:44 PM View: | Caple Kim Director | Castle Biosciences Inc (CSTL) | 25-May-24 | Option Exercise | 8,636 | -- | -- | 184% 4.71K to 13.34K | |
| 29-May-24 4:41 PM View: | Goldberg Ellen Director | Castle Biosciences Inc (CSTL) | 25-May-24 | Option Exercise | 8,636 | -- | -- | 91% 9.51K to 18.14K | |
| 29-May-24 4:46 PM View: | Bradbury Daniel Director | Castle Biosciences Inc (CSTL) | 25-May-24 | Option Exercise | 8,636 | -- | -- | 186% 4.66K to 13.29K | |
| 29-May-24 4:43 PM View: | Cole G Bradley Director | Castle Biosciences Inc (CSTL) | 25-May-24 | Option Exercise | 8,636 | -- | -- | 186% 4.66K to 13.29K |
